Login / Signup

Comparison of low- and high-dose recombinant activated factor VII for postcardiac surgical bleeding.

Aly Makram Habib
Published in: Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine (2016)
In this report, Low-dose rFVIIa showed equivalent efficacy and safety to high-dose rFVIIa. Further prospective randomized studies are needed to confirm these findings.
Keyphrases
  • high dose
  • low dose
  • stem cell transplantation
  • double blind
  • open label
  • placebo controlled
  • phase iii
  • atrial fibrillation
  • phase ii
  • clinical trial